Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Janux Therapeutics Inc’s stock clocked out at $53.68, down -0.45% from its previous closing price of $53.92. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 1.01 million shares were traded. JANX stock price reached its highest trading level at $54.9699 during the session, while it also had its lowest trading level at $50.51.
Ratios:
To gain a deeper understanding of JANX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 38.80 and its Current Ratio is at 38.80. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $69.
On September 06, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $70.
On May 30, 2024, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $47.Scotiabank initiated its Sector Perform rating on May 30, 2024, with a $47 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 01 ’24 when Reardon Tighe bought 5,202 shares for $53.44 per share.
Lichter Jay bought 1,139 shares of JANX for $60,723 on Nov 01 ’24. On Nov 01 ’24, another insider, Avalon Ventures XI, L.P., who serves as the 10% Owner of the company, bought 56,440 shares for $53.66 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JANX now has a Market Capitalization of 2817233664 and an Enterprise Value of 2182512384. For the stock, the TTM Price-to-Sale (P/S) ratio is 214.73 while its Price-to-Book (P/B) ratio in mrq is 4.28. Its current Enterprise Value per Revenue stands at 167.255 whereas that against EBITDA is -26.019.
Stock Price History:
Over the past 52 weeks, JANX has reached a high of $65.60, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is 9.20%, while the 200-Day Moving Average is calculated to be 27.62%.
Shares Statistics:
It appears that JANX traded 592.80K shares on average per day over the past three months and 653770 shares per day over the past ten days. A total of 46.25M shares are outstanding, with a floating share count of 42.34M. Insiders hold about 19.31% of the company’s shares, while institutions hold 84.95% stake in the company. Shares short for JANX as of 1728950400 were 4332266 with a Short Ratio of 7.31, compared to 1726185600 on 3305621. Therefore, it implies a Short% of Shares Outstanding of 4332266 and a Short% of Float of 16.420001.
